Novo Nordisk A/S
Time frame: 1 May 2023 - 30 April 2024Article ‘Count’ and ‘Share’ for Novo Nordisk A/S based on listed parameters only.
The articles listed below published by authors from Novo Nordisk A/S, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
| Journal | Count | Share |
|---|---|---|
|
American Journal of Human Genetics |
1 | 0.05 |
|
Angewandte Chemie International Edition |
1 | 0.13 |
|
Cell Metabolism |
1 | 0.08 |
|
Chemical Science |
1 | 0.92 |
|
Circulation |
2 | 0.35 |
|
Diabetes Care |
5 | 2.11 |
|
Hepatology |
1 | 0.27 |
|
International Journal of Epidemiology |
1 | 0.02 |
|
International Journal of Obesity |
2 | 0.88 |
|
JAMA: The Journal of the American Medical Association |
1 | 0.33 |
|
Journal of Clinical Endocrinology & Metabolism |
2 | 0.40 |
|
Journal of Clinical Investigation |
1 | 0.19 |
|
Journal of Hepatology |
1 | 0.14 |
|
Journal of the American College of Cardiology |
3 | 0.43 |
|
Kidney International |
2 | 0.27 |
|
Nature |
3 | 0.20 |
|
Nature Cell Biology |
1 | 0.15 |
|
Nature Chemistry |
1 | 0.13 |
|
Nature Communications |
5 | 1.14 |
|
Nature Genetics |
2 | 0.01 |
|
Nature Medicine |
3 | 0.63 |
|
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.63 |
|
Science Advances |
1 | 0.02 |
|
Science Translational Medicine |
1 | 0.02 |
|
The Lancet |
5 | 1.70 |
|
The Lancet Diabetes & Endocrinology |
2 | 0.76 |
|
The Lancet Neurology |
1 | 0.06 |
|
The New England Journal of Medicine |
6 | 1.65 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.